Arizona · 90620

Meningococcal Recombinant Protein And Outer Membrane Vesicle Vaccine, Serogroup B in Arizona

Arizona Medicare Avg
$150.03
10% below national avg
National Medicare Avg
$165.91
All states combined
Billed Charge (AZ)
$249.71
What providers submit
Est. Commercial (AZ)
$442.58
National avg: $493.55
Est. Cash / Self-Pay (AZ)
$214.26
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

28
Services in AZ
22
Providers
N/A
Min Payment
N/A
Max Payment

Arizona Pricing in Context

In Arizona, CPT code 90620 (Meningococcal Recombinant Protein And Outer Membrane Vesicle Vaccine, Serogroup B) carries an average Medicare payment of $150.03 — 10% below the national benchmark of $165.91. 22 providers across the state submitted claims for this procedure in 2023, performing 28 total services. Individual payments in AZ ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Arizona is $249.71, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Arizona sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Vaccines & Injections procedures, the estimated commercial insurance price in Arizona lands near $442.58, with self-pay cash prices typically around $214.26. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Meningococcal Recombinant Protein And Outer Membrane Vesicle Vaccine, Serogroup B cost in Arizona?

The average Medicare payment for Meningococcal Recombinant Protein And Outer Membrane Vesicle Vaccine, Serogroup B in Arizona is $150.03, which is 10% below the national average of $165.91. Providers in AZ typically bill $249.71 for this procedure.

What does Meningococcal Recombinant Protein And Outer Membrane Vesicle Vaccine, Serogroup B cost with insurance in Arizona?

With commercial insurance in Arizona, Meningococcal Recombinant Protein And Outer Membrane Vesicle Vaccine, Serogroup B costs an estimated $442.58. Without insurance, the estimated cash price is $214.26. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Meningococcal Recombinant Protein And Outer Membrane Vesicle Vaccine, Serogroup B in Arizona?

22 providers in Arizona billed Medicare for Meningococcal Recombinant Protein And Outer Membrane Vesicle Vaccine, Serogroup B in 2023, performing 28 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Meningococcal Recombinant Protein And Outer Membrane Vesicle Vaccine, Serogroup B cheaper in Arizona than the national average?

Yes — Meningococcal Recombinant Protein And Outer Membrane Vesicle Vaccine, Serogroup B costs 10% below the national average in Arizona. The state average Medicare payment is $150.03 compared to $165.91 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial